Sign in or Create Account to see detailed information, compare products and read or write reviews.

YOU MUST BE AT LEAST 18 YEARS OLD TO ACCESS THIS WEBSITE. IF YOU ARE UNDER 18 YEARS OLD YOU ARE NOT PERMITTED TO USE THIS WEBSITE FOR ANY REASON.

Before signing in or creating an account you agree:

  • That you are seeking information about Medical Cannabis.
  • That nothing on this website is intended to or should be taken to promote, advertise, or induce the use or supply of medical cannabis for medical diagnosis or treatment.
  • That you are 18 years of age or older

CANNABIS IS A SCHEDULED AND REGULATED DRUG.

Cannabis may have negative side effects or interactions with other medications. Cannabis is a prescription only medication in Australia and is not available for purchase by the general public.

*Required due to regulations.

sundaze

Callisto

10g
High THC CBD THC Sativa Dominant

Flower

LA S.A.G.E

THC 22%

CBD <1%

Category 5
Schedule 8
Finished Product
In Stock
Updated: 15/05/24
$139 RRP
$13.90 g / $0.06 mg

Sundaze Callisto T22 is a Sativa dominant THC flower. Patients describe it as an energetic strain that enhances mood. The strain has a pine, sage and sweet taste with dense flowers covered in resin. Dominant terpenes are Terpinolenene, beta-Caryophyllene, and D-Limonene. 

Spot an error? Please let us know

Based on 22 reviews

Top reported conditions % say it helps
Chronic Pain (Non-Cancer) 100%
Anxiety 100%
Depression 100%
Neuropathic Pain 100%
ADD/ADHD 100%

Top reported effects

  1. Calming
  2. Energetic
  3. Happy
  4. Creative
  5. Relaxed

Top reported flavours/scents

Citrus
Earthy
Sweet
Sage
Woody
Information above is compiled from real patient reviews - it is not to be taken as medical advice. Cannabis may have side effects or interactions with other medications. Medical Cannabis is not effective for everyone and more research is needed. Please consult a health professional for advice.
community photo of sundaze Callisto Flower 10g
community photo of sundaze Callisto Flower 10g

Photos shared by patients